Surrozen names Andrew Maleki as CFO

Andrew Maleki has joined the Surrozen (SRZN) management team as CFO. Maleki brings more than a decade of experience in the biotech industry spanning corporate strategy, business development and operational leadership, including playing a key role in raising over $500M in capital. Most recently, he led corporate development and program leadership at Lassen Therapeutics, where he helped shape portfolio strategy and business development efforts.